Different requirements for alpha-galactosylceramide and recombinant IL-12 antitumor activity in the treatment of C-26 colon carcinoma hepatic metastases. (Q45880265)
scientific article published in October 2001
Language:
Current Data About Different requirements for alpha-galactosylceramide and recombinant IL-12 antitumor activity in the treatment of C-26 colon carcinoma hepatic metastases.
(P31) (Q13442814)
(P248)
(P698) 11592087
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11592087%20AND%20SRC:MED&resulttype=core&format=json
(P813) Tuesday, November 12, 2019

(P50) (Q41570231)
(P1545) 7
(P248)
(P698) 11592087
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11592087%20AND%20SRC:MED&resulttype=core&format=json
(P813) Tuesday, November 12, 2019

(Q57051232)
(P1545) 2
(P248)
(P698) 11592087
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11592087%20AND%20SRC:MED&resulttype=core&format=json
(P813) Tuesday, November 12, 2019

(Q57087548)
(P1545) 4
(P248)
(P698) 11592087
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11592087%20AND%20SRC:MED&resulttype=core&format=json
(P813) Tuesday, November 12, 2019

(P304) 3101-3110
(P248)
(P698) 11592087
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11592087%20AND%20SRC:MED&resulttype=core&format=json
(P813) Tuesday, November 12, 2019

(P407) (Q1860)

(P433) 10
(P248)
(P698) 11592087
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11592087%20AND%20SRC:MED&resulttype=core&format=json
(P813) Tuesday, November 12, 2019

(P478) 31
(P248)
(P698) 11592087
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11592087%20AND%20SRC:MED&resulttype=core&format=json
(P813) Tuesday, November 12, 2019

(P577) Monday, October 1, 2001
(P248)
(P698) 11592087
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11592087%20AND%20SRC:MED&resulttype=core&format=json
(P813) Tuesday, November 12, 2019

(P921) (Q18554829)
(P887)

(P1433) (Q5412727)
(P248)
(P698) 11592087
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11592087%20AND%20SRC:MED&resulttype=core&format=json
(P813) Tuesday, November 12, 2019

(P1476) "Different requirements for alpha-galactosylceramide and recombinant IL-12 antitumor activity in the treatment of C-26 colon carcinoma hepatic metastases" (language: en)
(P248)
(P698) 11592087
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11592087%20AND%20SRC:MED&resulttype=core&format=json
(P813) Tuesday, November 12, 2019

(P2093) C Chiodoni
(P1545) 1
(P248)
(P698) 11592087
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11592087%20AND%20SRC:MED&resulttype=core&format=json
(P813) Tuesday, November 12, 2019

S Sangaletti
(P1545) 3
(P248)
(P698) 11592087
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11592087%20AND%20SRC:MED&resulttype=core&format=json
(P813) Tuesday, November 12, 2019

B Cappetti
(P1545) 5
(P248)
(P698) 11592087
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11592087%20AND%20SRC:MED&resulttype=core&format=json
(P813) Tuesday, November 12, 2019

Y Koezuka
(P1545) 6
(P248)
(P698) 11592087
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11592087%20AND%20SRC:MED&resulttype=core&format=json
(P813) Tuesday, November 12, 2019

(P2860) (Q28254991)
(P248)
(P854) https://api.crossref.org/works/10.1002%2F1521-4141%282001010%2931%3A10%3C3101%3A%3AAID-IMMU3101%3E3.0.CO%3B2-8
(P813) Sunday, January 21, 2018

(Q41464349)
(P248)
(P854) https://api.crossref.org/works/10.1002%2F1521-4141%282001010%2931%3A10%3C3101%3A%3AAID-IMMU3101%3E3.0.CO%3B2-8
(P813) Sunday, January 21, 2018

(Q52525223)
(P248)
(P854) https://api.crossref.org/works/10.1002%2F1521-4141%282001010%2931%3A10%3C3101%3A%3AAID-IMMU3101%3E3.0.CO%3B2-8
(P813) Sunday, January 21, 2018

(Q36096376)
(P248)
(P854) https://api.crossref.org/works/10.1002%2F1521-4141%282001010%2931%3A10%3C3101%3A%3AAID-IMMU3101%3E3.0.CO%3B2-8
(P813) Sunday, January 21, 2018

(Q41815553)
(P248)
(P854) https://api.crossref.org/works/10.1002%2F1521-4141%282001010%2931%3A10%3C3101%3A%3AAID-IMMU3101%3E3.0.CO%3B2-8
(P813) Sunday, January 21, 2018

(Q36363483)
(P248)
(P854) https://api.crossref.org/works/10.1002%2F1521-4141%282001010%2931%3A10%3C3101%3A%3AAID-IMMU3101%3E3.0.CO%3B2-8
(P813) Sunday, January 21, 2018

(Q41906195)
(P248)
(P854) https://api.crossref.org/works/10.1002%2F1521-4141%282001010%2931%3A10%3C3101%3A%3AAID-IMMU3101%3E3.0.CO%3B2-8
(P813) Sunday, January 21, 2018

(Q52042067)
(P248)
(P854) https://api.crossref.org/works/10.1002%2F1521-4141%282001010%2931%3A10%3C3101%3A%3AAID-IMMU3101%3E3.0.CO%3B2-8
(P813) Sunday, January 21, 2018

(Q53400482)
(P248)
(P854) https://api.crossref.org/works/10.1002%2F1521-4141%282001010%2931%3A10%3C3101%3A%3AAID-IMMU3101%3E3.0.CO%3B2-8
(P813) Sunday, January 21, 2018

(Q41886939)
(P248)
(P854) https://api.crossref.org/works/10.1002%2F1521-4141%282001010%2931%3A10%3C3101%3A%3AAID-IMMU3101%3E3.0.CO%3B2-8
(P813) Sunday, January 21, 2018

(Q24290619)
(P248)
(P854) https://api.crossref.org/works/10.1002%2F1521-4141%282001010%2931%3A10%3C3101%3A%3AAID-IMMU3101%3E3.0.CO%3B2-8
(P813) Sunday, January 21, 2018

(Q28267397)
(P248)
(P854) https://api.crossref.org/works/10.1002%2F1521-4141%282001010%2931%3A10%3C3101%3A%3AAID-IMMU3101%3E3.0.CO%3B2-8
(P813) Sunday, January 21, 2018

(Q41546511)
(P248)
(P854) https://api.crossref.org/works/10.1002%2F1521-4141%282001010%2931%3A10%3C3101%3A%3AAID-IMMU3101%3E3.0.CO%3B2-8
(P813) Sunday, January 21, 2018

(Q73889862)
(P248)
(P854) https://api.crossref.org/works/10.1002%2F1521-4141%282001010%2931%3A10%3C3101%3A%3AAID-IMMU3101%3E3.0.CO%3B2-8
(P813) Sunday, January 21, 2018

(Q73162615)
(P248)
(P854) https://api.crossref.org/works/10.1002%2F1521-4141%282001010%2931%3A10%3C3101%3A%3AAID-IMMU3101%3E3.0.CO%3B2-8
(P813) Sunday, January 21, 2018

(Q62230500)
(P248)
(P854) https://api.crossref.org/works/10.1002%2F1521-4141%282001010%2931%3A10%3C3101%3A%3AAID-IMMU3101%3E3.0.CO%3B2-8
(P813) Sunday, January 21, 2018

(Q63363342)
(P248)
(P854) https://api.crossref.org/works/10.1002%2F1521-4141%282001010%2931%3A10%3C3101%3A%3AAID-IMMU3101%3E3.0.CO%3B2-8
(P813) Sunday, January 21, 2018

(Q63363350)
(P248)
(P854) https://api.crossref.org/works/10.1002%2F1521-4141%282001010%2931%3A10%3C3101%3A%3AAID-IMMU3101%3E3.0.CO%3B2-8
(P813) Sunday, January 21, 2018

(Q72508185)
(P248)
(P854) https://api.crossref.org/works/10.1002%2F1521-4141%282001010%2931%3A10%3C3101%3A%3AAID-IMMU3101%3E3.0.CO%3B2-8
(P813) Sunday, January 21, 2018

(Q73256881)
(P248)
(P854) https://api.crossref.org/works/10.1002%2F1521-4141%282001010%2931%3A10%3C3101%3A%3AAID-IMMU3101%3E3.0.CO%3B2-8
(P813) Sunday, January 21, 2018

(Q70340237)
(P248)
(P854) https://api.crossref.org/works/10.1002%2F1521-4141%282001010%2931%3A10%3C3101%3A%3AAID-IMMU3101%3E3.0.CO%3B2-8
(P813) Sunday, January 21, 2018

other details